Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009

... immunoassay kits for quantitative measurement of immunosuppressant drug levels. Each kit includes reagents, ... some of the analytical weaknesses of immunoassay immunosuppressant drug measurement. The new MassTrak ... kit specifically designed to quantify the immunosuppressant tacrolimus in kidney and liver transplant ...

More stringent evaluation on the use of generic medications in thoracic transplantation

... Thoracic transplant patients require immunosuppressant medications that are classified by regulating ... represent the challenges faced in prescribing immunosuppressant medication in transplant recipients. Many times, ... care professionals caring for them if their immunosuppressant medication has been changed Education of ...

'Multi-target' immune therapy improves outcomes of severe lupus nephritis

... that is traditionally treated with a single immunosuppressant drug, but the efficacy is very poor," says Dr. ... different immune targets with a combination of immunosuppressant drugs." One group of patients received this "multi-target" therapy, consisting of the immunosuppressant drugs tacrolimus and mycophenolate ...

Cyclosporine Eye Drops a Good Deal for Dry Eye

... immunosuppressant works where other lubricants fail, study shows TUESDAY, Feb. 10 (HealthDay News) -- Eye drops that contain the immunosuppressant drug cyclosporine may be a cost-effective treatment for dry eye syndrome ...

Study concludes no racial disparities in long-term outcomes in recipients of liver transplants

... Results were analyzed during two time periods correlating to the primary immunosuppressant drug used during that era (cyclosporine from 1984-1993 and tacrolimus from 1994-2007). The use of the modern immunosuppressant drug tacrolimus substantially reduced the risk of acute rejection, graft ...

New Jefferson study may redefine how a chronic auto-immune disease is diagnosed

... such as prednisone, plasmapheresis (plasma exchange) and intravenous immunoglobulin (IVIg). IVIg may be used even as a first-line therapy. immunosuppressant drug therapy may be effective in patients who fail standard therapy. Physiotherapy may improve muscle strength, balance, function and mobility, and ...

Leukemia Risk From MS Drug May Be Up

... (Novantrone), an estimated 7.4 people will develop acute leukemia, compared with fewer than 2.5 people in prior estimates. Mitoxantrone is an immunosuppressant approved by the U.S. Food and Drug Administration for treatment of secondary progressive MS. In the study, about 0.74 percent of people taking the ...

Risk of Leukemia with Multiple Sclerosis Drug Higher Than Thought

... Late-breaking Science Program at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 - May 2, 2009. Mitoxantrone is an immunosuppressant drug approved by the FDA for treatment of several forms of advancing MS. It is one of only two drugs that has been shown to benefit people with ...

Mayo Clinic researchers formulate treatment combination lethal to pancreatic cancer cells

... available for treatment of patients. Panobinostat is approved as therapy for cutaneous T cell lymphoma (CTCL), and rapamycin is best known as an immunosuppressant to help prevent rejection of transplanted organs. "We need new therapies and strategies for the treatment of pancreatic cancer because these ...

Study reports success in treating a rare retinal disorder

... patients are undertreated because we do not have good markers to evaluate treatment effects," observes Heckenlively. "Now that we have evidence that immunosuppressant therapies work, we need further studies to evaluate which medications will be effective in treating autoimmune retinopathy." ...

More>>

Immunosuppressant in Medical Technology

CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI

... cases generally had risk factors for PML, including treatment with immunosuppressant therapies and impairment of immune function. In immunosuppressed ... not use CellCept unless she cannot be successfully treated with other immunosuppressant drugs. If this drug is used during pregnancy, or if the patient ...

Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function

... cases generally had risk factors for PML, including treatment with immunosuppressant therapies and impairment of immune function. In immunosuppressed ... not use CellCept unless she cannot be successfully treated with other immunosuppressant drugs. If this drug is used during pregnancy, or if the patient ...

ADVENTRX Announces Results From ANX-514 Bioequivalence Study

... reactions. Docetaxel is an anti-cancer agent that acts by disrupting the cellular microtubular network that is essential for cell division. immunosuppressant premedication is recommended for docetaxel therapy to reduce the incidence and severity of hypersensitivity reactions. Docetaxel is approved to ...

Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy

... to end-stage renal disease requiring dialysis or kidney transplant. Current treatments for IgA nephropathy include blood pressure control, diet and immunosuppressant drugs. Approximately 30 percent of IgA nephropathy patients do not respond to current therapies. About Osprey Pharmaceuticals U.S.A. ...

ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study

... reactions. Docetaxel is an anti-cancer agent that acts by disrupting the cellular microtubular network that is essential for cell division. immunosuppressant premedication is recommended for docetaxel therapy to reduce the incidence and severity of hypersensitivity reactions. Docetaxel is approved to treat ...

Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment

... in patients treated with a TNF antagonist cannot be excluded. All patients, and in particular patients with a medical history of extensive immunosuppressant therapy or psoriasis patients with a history of PUVA treatment, should be examined for the presence of non-melanoma skin cancer prior to and during ...

Pixantrone Shows Activity in a Preclinical Study of Experimental Autoimmune Myasthenia Gravis (EAMG)

... improving both the laboratory and the clinical manifestations of the MG equivalent in rats. The authors concluded that "pixantrone [is] a promising immunosuppressant agent suitable for clinical investigation in myasthenia gravis, although additional experiments are needed to confirm its safety profile in prolonged ...

Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis

... to patients undergoing treatment for inflammatory arthritis, including those that were being taken by the patient, are recognized to have immunosuppressant effects. About tgAAC94 and the Phase I/II Study tgAAC94 is being developed as a supplemental therapeutic to systemic anti-TNF-alpha protein therapy ...

Early Results of the CellCept Spare the Nephron Study Examine Kidney Function

... of these regimens on renal function. About CellCept CellCept is an immunosuppressant or anti-rejection drug approved for use in combination with other ... lung disorder, pleural effusion, tremor and insomnia. Patients receiving immunosuppressant regimens are at increased risk of developing lymphomas and other ...

Aspreva and Roche Announce Preliminary Results for Phase III Study Evaluating CellCept in Lupus Nephritis

... call. About CellCept CellCept (mycophenolate mofetil, MMF) is an immunosuppressant or anti-rejection drug approved for use in combination with ... lung disorder, pleural effusion, tremor and insomnia. Patients receiving immunosuppressant regimens are at increased risk of developing lymphomas and ...

More>>

Immunosuppressant in Medical Products

Lyphochek Elevated Immunosuppressant Control

Description:... Lyphochek Elevated immunosuppressant Control is a bilevel Cyclosporine control product, prepared from human ... in transplant patients at two hours post-dose. Lyphochek Elevated immunosuppressant Control can also be used with the Lyphochek Whole Blood Control, providing ...
Company:Bio-Rad Laboratories

Immunosuppressant in Medical Dictionary

Immunosuppressant drugs

... immunosuppressant drugs have been used for many years to treat ... hormone ( ACTH ); and azathioprine. Taking immunosuppressant drugs after an organ transplant . Being ... for Hodgkin's lymphoma . In recent years, immunosuppressant drugs have been utilized with fair success to ...

Organ Transplant

... advanced ability to perform tissue and organ transplant s has also increased the number of people vulnerable to fungal infection s. Taking immunosuppressant drugs after an organ transplant . Being exposed to certain pesticides . A diet high in meats and fat . Past treatment for Hodgkin's ...

Pesticides

... odors or fumes, such as from perfume, paint, or hair spray, pesticides , household cleaners • smoke from a wood-burning fire ... Taking immunosuppressant drugs after an organ transplant . Being exposed to certain pesticides . A diet high in meats and fat . Past treatment for Hodgkin's ...

Phlebotomy

... You also will be treated for underlying disease s - for example, interferon and other medications for viral hepatitis , corticosteroids or other immunosuppressant medications for autoimmune hepatitis , and phlebotomy , ... ...

Potassium

... of sodium (salt), potassium , protein and fluids in the diet may be necessary. Sometimes bedrest is advised. Steroids, or more powerful immunosuppressant drugs may be given to reduce the inflammation . HYPOKALEMIA - Abnormal decrease in blood potassium concentration. Can result in cardiac ...

More>>

Immunosuppressant in Biological News

Immunosuppressant further linked to birth defects

... taken mycophenolate mofetil (MMF), a widely used immunosuppressant available commercially as Cellcept. The findings ... not occurred. The fetal side-effects of several immunosuppressant drugs have been studied, though not for widely ... newer medications, such as (MMF). The use of immunosuppressant drugs is a required, life-long treatment for ...

Researchers engineer pancreatic cell transplants to evade immune response

... is limited because transplant recipients are forced to take powerful immunosuppressant medications that have toxic side effects and raise the risk of infection. ... such transplants can control type 1 diabetes, recipients must take immunosuppressant medications in order to prevent rejection of these beta foreign cells. ...

Promising 3-year data: Saving limbs with drug-eluting stents

... limb ischemia and who underwent infrapopliteal revascularization with angioplasty and placement of either a drug-eluting stent (with sirolimus, an immunosuppressant drug) or a bare-metal stent (without a drug coating). The patients had regular follow-ups up to three years, and researchers studied how they did by ...

Cancer-causing gene discovery suggests new therapies

... already available to counter this increased protein production could slow or stop cancer's runaway growth induced by Myc. Rapamycin, for example, an immunosuppressant drug already in clinical trials for cancer, might help treat cancers where Myc is over active, the scientists suggest. The discovery was led by ...

REGiMMUNE receives $12 million in grants to develop transplant and allergy drugs

... will develop its reVax drug for cedar allergy; and the three-year grant from NIBIO will fund the development of its ToleroVax drug (RGI-2001), a new immunosuppressant for Graft-versus-Host Disease (GvHD) associated with stem cell transplantation. "The substantial funds that REGiMMUNE is receiving from these two ...

Top biophysics award to Professor Ray Norton

... drugs based on marine cone snail toxins may be able to break the link with such long-term dependence. The sea anemone, from which an effective immunosuppressant has been obtained, could assist in the treatment of multiple sclerosis one key characteristic of this disease being the errant immune system's ...

Adult stem cells activated in mammalian brain

... drugs to prevent the body from rejecting the treatment. But, working with a patient's own cells would eliminate the need for transplantation and immunosuppressant drugs and may be a better alternative, scientists say. Ependymal cells line the fluid-filled ventricles, so a drug to activate the cells could ...

Engineer develops detergent to promote peripheral nerve healing

... the two ends of the severed nerve to promote regrowth. And because the immunogenic lipid components have been extracted, patients don't require immunosuppressant drugs. AxoGen learned about the detergent processing work in Schmidt's lab, licensed it and combined it with the University of Florida enzyme ...

Promising new drug targets identified for Huntington's disease

... building up. However, there are currently no treatments available that slow the neurodegeneration in people with Huntington's disease. Rapamycin, an immunosuppressant used to lower the body's natural immunity in patients who receive kidney transplants, is the most promising candidate drug currently available but ...

Genetic technology reveals how poisonous mushrooms cook up toxins

... pathways by which natural products are synthesized in fungi. Fungal natural products that benefit human health include penicillin and the immunosuppressant drug cyclosporin. Studying their biosynthesis could lead to the discovery and development of new medicines. To find the elusive gene for ...

More>>

Immunosuppressant in Biological Technology

Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients

... FDA in March 2006. (Logo: http://www.newscom.com/cgi-bin/prnh/20090528/SF23579LOGO ) "Prograf + MMF has been an accepted and successful immunosuppressant regimen for the transplant community for more than 10 years," said Flavio Vincenti, M.D., Professor of Clinical Medicine, University of California, ...

New Biologic STELARA(TM) Receives Approval in Europe for Treatment of Moderate to Severe Plaque Psoriasis

... have exclusive marketing rights in all countries outside of the United States. Important Safety Information STELARA is a selective immunosuppressant and may have the potential to increase the risk of infections and reactivate latent infections. Serious infections have been observed in patients ...

ADVENTRX Announces Further Cost-Cutting Measures

... reactions. Docetaxel is an anti-cancer agent that acts by disrupting the cellular microtubular network that is essential for cell division. immunosuppressant premedication is recommended for docetaxel therapy to reduce the incidence and severity of hypersensitivity reactions. Docetaxel is approved to treat ...

University of Minnesota Receives $40 Million for Type 1 Diabetes Research

... of Minnesota researchers have sought a cure for type 1 diabetes through developing both an abundant supply of islet cells and better and safer immunosuppressant techniques. A team led by David Sutherland, M.D., Ph.D., co-director of the Schulze Diabetes Institute and founder of the former DIIT, was ...

Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis

... in patients treated with a TNF antagonist cannot be excluded. All patients, and in particular patients with a medical history of extensive immunosuppressant therapy or psoriasis patients with a history of PUVA treatment, should be examined for the presence of non-melanoma skin cancer prior to and during ...

A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA)

... method for the simultaneous determination of four immunosuppressant drugs: Cyclosporin A (CsA), Tacrolimus (TAC, aka ... interest in extending it to include a fifth immunosuppressant drug, Mycophenolic Acid (MPA, see structure in ... MPA is the pharmacologically active form of the immunosuppressant prodrug Mycophenolate Mofetil. Because its ...